Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis

Abstract

OBJECTIVE: Major depressive disorder (MDD) affects about 10-15% of the general population in a lifetime. A considerable number of patients fail to achieve full symptom remission despite adequate treatment and are considered treatment resistant (TRD). The current study compared the relative efficacy and tolerability of pharmacological and somatic TRD interventions by means of a Bayesian network meta-analysis. RESEARCH DESIGN AND METHODS: An electronic literature search of MEDLINE, MEDLINE In-Process, EMBASE, PsycInfo, EconLit and Cochrane Library databases for trials published between September 2003 and September 2014 was conducted. Key outcomes extracted were disease severity change from baseline, response and remission rates at various timepoints and discontinuation due to adverse events. RESULTS: Of the 3876 abstracts identified, 31 publications/randomised controlled trials (RCTs) were included in the analysis; 19 RCTs investigating 13 pharmacological interventions and 12 RCTs investigating electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS). The evidence synthesis investigating efficacy outcomes of TRD treatments demonstrated superior efficacy for ketamine compared to pharmacological and somatic interventions at 2 weeks after treatment initiation. At 4, 6 and 8 weeks, quetiapine augmentation (800 mg/day) and risperidone augmentation were found to be the first and second best treatments, respectively. Networks were small for response rate and remission rate outcomes at most timepoints. The most tolerable treatment was lamotrigine augmentation showing a comparable profile to placebo/sham. CONCLUSIONS: This analysis revealed scarcity of long-term data on sustained remission that would allow a comparative long-term efficacy assessment. Key limitations of the analysis can be considered the search timeframe and the use of mapping formula for the depression scores.

Overview

Integrity signals

Registry

Crossref · 10.1080/03007995.2016.1277201

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 68 references

Research works printed but not linked: 6

  1. Thase MERA., 1997, J Clin Psychiatry, 58, 23
  2. Souery DPG, 2006, J Clin Psychiatry, 67, 16
  3. 2009, Symbyax
  4. Singh J, 2014, Biol Psychiatry, 1, 44S
  5. Thase MEFMHM, 2011, ACNP 50th Annual Meeting
  6. Zhang XHWLW, 2011, Shanghai Arch Psychiatry, 17

Cited by

See all 91

Metadata

Authors
Papadimitropoulou, K., Vossen, C., Karabis, A., Donatti, C., & Kubitz, N.
Affiliations
  • Mapi Group, Houten, Netherlands;
  • Janssen (United Kingdom) (GB)
  • Janssen-Cilag GmbH, Neuss, Germany
Corresponding author
Papadimitropoulou, Katerina
Venue
Current Medical Research and Opinion
Published
2017-02-06
Volume
33
Issue
4
Pages
701-711
ISSN
  • 0300-7995 (ISSN-L)
  • 1473-4877
OpenAlex
W2567253990
Cited by
91
References
68
Citations by year
2026: 5 · 2025: 9 · 2024: 8 · 2023: 5 · 2022: 8 · 2021: 20 · 2020: 12 · 2019: 10 · 2018: 9 · 2017: 5
FWCI
0.92
Type
journal article
Language
en
Open access
closed
Locations
  • Current Medical Research and Opinion (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
Keywords
treatment-resistant depression, major depressive disorder, electroconvulsive therapy, repetitive transcranial magnetic stimulation, ketamine, pharmacological interventions, somatic interventions, treatment response, remission, tolerability, adverse events
MeSH terms
Network Meta-Analysis, Adult, Bayes Theorem, Major Depressive Disorder, Depressive Disorder, Major, Humans, Psychotropic Drugs, Remission Induction, Time, Treatment Outcome, Transcranial Magnetic Stimulation, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis. https://app.cochat.ai/papers/10.1080/03007995.2016.1277201
The paper
Papadimitropoulou, K., Vossen, C., Karabis, A., Donatti, C., & Kubitz, N. (2017). Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2016.1277201

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.